The Full Perspective: Another look at Lemonade’s IPO and Allstate’s $4bn acquisition of NatGen
Description
Each Friday the Insider Publishing team dissect the week's biggest stories on, The Full Perspective.
One of the biggest stories in the US over the past few weeks has been Lemonade's IPO. This week we take another look at what's developed since the IPO including:
- Consequences of the IPO and high valuation
- Does the valuation increase risk?
- Imbalance of supply and demand
- Growth, disruption, and challenges
We also touch on Allstate's $4bn acquisition of NatGen.
Related reading:
- Lemonade IPO: A unicorn vomiting a rainbow: https://bit.ly/2DkvsX2
- Lemonade – The path forward: https://bit.ly/3fhB2rl
- Allstate to buy NatGen for $4bn: https://bit.ly/2AIWBSC
Global intelligence that enables you to act first:
Take a 14-day free trial to Inside P&C: https://bit.ly/2DtmaIt
Support the show (https://insuranceinsider.com/free-trial)
United States
